<DOC>
	<DOCNO>NCT00104338</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness new oral immunosuppressant agent compare standard care renal transplant patient diagnose BK nephropathy .</brief_summary>
	<brief_title>Study FK778 Renal Transplant Recipients With Untreated BK Nephropathy</brief_title>
	<detailed_description>The purpose study assess efficacy safety FK778 compare standard care renal transplant recipient newly diagnose untreated BK nephropathy .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<criteria>Renal transplant recipient newly diagnose BK nephropathy . Previous treatment BK nephropathy Organ transplant kidney Uncontrolled concomitant infection BK nephropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Investigational Therapies</keyword>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Immunosuppressant</keyword>
	<keyword>BK Nephropathy</keyword>
	<keyword>Polyomavirus , BK</keyword>
	<keyword>Human Polyomavirus BK</keyword>
	<keyword>Polyomavirus hominis 1</keyword>
</DOC>